No Data
Growth 250 has risen for four consecutive days, and Sanbio has significantly increased = Emerging Markets, Day 1.
The Tokyo Stock Exchange Growth Market 250 Index has risen for four consecutive days. With limited selling demand during the holiday gap, a gradual upward trend is observed. SanBio <4592.T> has significantly increased, and iSpace <9348.T>, Heartseed <219A.T>, and QPS Research Institute <5595.T> have also risen. Kawaris <153A.T>, which is taking measures against unauthorized logins, reached the maximum increase, and Ortz <260A.T>, which had overstated its results, completely matched for the first time in three business days due to an expansion of price limits. Provided by Well.
Growth 250 slightly declines, while Syns etc. rise = Emerging Markets, 24th.
The Tokyo Stock Exchange Growth Market 250 Index has slightly declined. Major stocks showed mixed performance, resulting in a lack of direction for the index. Space ventures such as Synspective <290A.T>, QPS Research <5595.T>, and Astroscale Holdings <186A.T> have risen. On the other hand, Sanbio <4592.T>, Trial <141A.T>, and Cover <5253.T> were sold off. The IPO (initial public offering) LIFE CREATE <352A.T> started with a modest increase.
SanBio: Extraordinary Report
Growth 250 continues to decline slightly, with Sambaio and others being sold off = Emerging Markets, 23rd.
The Tokyo Stock Exchange Growth Market 250 Index fell slightly. While the overall Tokyo market rose significantly due to the increase in U.S. stocks, the Growth Market was sluggish and fluctuated around the previous day's closing price. Sunbio <4592.T>, ABEJA <5574.T>, and Free <4478.T> were soft. QPS Research Institute <5595.T>, ispace <9348.T>, and Makuake <4479.T> were bought. The recently listed IPO, Digital Grid <350A.T>, rose initially before selling off.
SanBio: Confirmation
SanBio: Financial Report - 12th Term (2024/02/01 - 2025/01/31)
